-
AbbVie Inc. (ABBV $206.57)
- $206.57 P/E (TTM): 88.33X Cap: $364.91B
- View ABBV Profile
- View Questions on ABBV
Detailed Quote
Questions on this company?
Become a Member
Company Profile
{tplLang.businessdescription | toLang tLang}
{ profileData.description }
{tplLang.details | toLang tLang}
{tplLang.ceo | toLang tLang}
{profileData.profile.details.ceo}
{tplLang.employees | toLang tLang}
{profileData.profile.details.employees | numeraljs '0,0'}
{tplLang.issuetype | toLang tLang}
{profileData.profile.details.issuetype | asIssueType}
{tplLang.industryclassifications | toLang tLang}
{tplLang.sector | toLang tLang}
{profileData.profile.classification.sector}
{tplLang.industry | toLang tLang}
{profileData.profile.classification.industry}
{tplLang.toolname| toLang tLang}
There is no {tplLang.toolname| toLang tLang} currently available for
{data.symbolstring}.
Interactive Chart
Key Ratios
Earnings
Analyst Recommendations
5i Recent Questions
-
Amgen Inc. (AMGN $292.62)
- $292.62 P/E (TTM): 27.03X Cap: $157.53B
- View AMGN Profile
- View Questions on AMGN
-
Intuitive Surgical Inc. (ISRG $481.28)
- $481.28 P/E (TTM): 66.89X Cap: $172.52B
- View ISRG Profile
- View Questions on ISRG
-
AbbVie Inc. (ABBV $206.57)
- $206.57 P/E (TTM): 88.33X Cap: $364.91B
- View ABBV Profile
- View Questions on ABBV
-
Eli Lilly and Company (LLY $698.05)
- $698.05 P/E (TTM): 57.06X Cap: $660.67B
- View LLY Profile
- View Questions on LLY
-
Stryker Corporation (SYK $381.61)
- $381.61 P/E (TTM): 50.58X Cap: $145.89B
- View SYK Profile
- View Questions on SYK
-
Novo Nordisk A/S (NVO $53.75)
- $53.75 P/E (TTM): 14.88X Cap: $363.68B
- View NVO Profile
- View Questions on NVO
Q: I sold a portion of my NVO holdings a while ago, and am not inclined to buy it back just now. What would you see as the best buy in the US healthcare sector these days; possibly as a compliment to NVO, but not necessarily?
-
Amgen Inc. (AMGN $292.62)
- $292.62 P/E (TTM): 27.03X Cap: $157.53B
- View AMGN Profile
- View Questions on AMGN
-
Intuitive Surgical Inc. (ISRG $481.28)
- $481.28 P/E (TTM): 66.89X Cap: $172.52B
- View ISRG Profile
- View Questions on ISRG
-
AbbVie Inc. (ABBV $206.57)
- $206.57 P/E (TTM): 88.33X Cap: $364.91B
- View ABBV Profile
- View Questions on ABBV
-
Stryker Corporation (SYK $381.61)
- $381.61 P/E (TTM): 50.58X Cap: $145.89B
- View SYK Profile
- View Questions on SYK
-
UnitedHealth Group Incorporated (DE) (UNH $308.49)
- $308.49 P/E (TTM): 12.73X Cap: $279.39B
- View UNH Profile
- View Questions on UNH
-
iShares U.S. Medical Devices ETF (IHI $61.63)
- $61.63 P/E (TTM): 164.7X Cap: $4.32B
- View IHI Profile
- View Questions on IHI
Q: I have been reviewing my health care holdings and I am disappointed in the whole sector. Their percentage of my holdings has dropped, and if I rebalance I should be adding another 50% to these holdings. I am unhappy with IHI and UNH, even ISRG is in the doldrums. Your thoughts on adding to the health care sector and these companies/ETFs at this time. Are there other companies much better suited that I am missing. I am tempted to remove the whole sector from my portfolio, as I am comfortable with risk.
-
AbbVie Inc. (ABBV $206.57)
- $206.57 P/E (TTM): 88.33X Cap: $364.91B
- View ABBV Profile
- View Questions on ABBV
-
Harvest Healthcare Leaders Income ETF (HHL $7.25)
- $7.25 P/E (TTM): 56.1X Cap: $1.41B
- View HHL Profile
- View Questions on HHL
Q: I have been buying HHL ETF over the last number of months, but it continues to struggle. Would say this is just sector weakness and if so how do you see the sector - will it eventually recover? My only other Healthcare stock is is ABBV so I am not overly exposed but this ETF is close to a full position, for income. Are there any issues with the ETF, and are you cautious? Thanks so much.
Insiders
Share Information
SEC Filings
News and Media